Japan's Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.

Astellas Pharma Inc. says it will buy U.S. pharmaceutical company Iveric Bio Inc., which focuses on ophthalmology treatments, for about $5.9 billion, as the Japanese drugmaker continues its merger and acquisition drive.

Related Keywords

Japan ,Japanese ,Iveric Bio ,Astellas Us Holdings Inc ,Astellas Pharma Inc ,Iveric Bio Inc ,Nasdaq ,Astellas Pharma ,Astellas ,Japan Pharmaceutical ,Rugmaker Astellas ,S Pharmaceutical ,